Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Syndax Pharmaceuticals (SNDX) Revenue (2016 - 2020)

Syndax Pharmaceuticals has reported Revenue over the past 6 years, most recently at $380000.0 for Q4 2020.

  • Quarterly results put Revenue at $380000.0 for Q4 2020, changed 0.0% from a year ago — trailing twelve months through Sep 2021 was $380000.0 (down 74.95% YoY), and the annual figure for FY2025 was $172.4 million, up 627.84%.
  • Revenue for Q4 2020 was $380000.0 at Syndax Pharmaceuticals, roughly flat from $379000.0 in the prior quarter.
  • Over the last five years, Revenue for SNDX hit a ceiling of $1.2 million in Q4 2017 and a floor of $305000.0 in Q1 2016.
  • Median Revenue over the past 5 years was $379000.0 (2018), compared with a mean of $393950.0.
  • Biggest five-year swings in Revenue: skyrocketed 1694.12% in 2016 and later crashed 68.15% in 2018.
  • Syndax Pharmaceuticals' Revenue stood at $305000.0 in 2016, then soared by 291.15% to $1.2 million in 2017, then crashed by 68.15% to $380000.0 in 2018, then changed by 0.0% to $380000.0 in 2019, then changed by 0.0% to $380000.0 in 2020.
  • The last three reported values for Revenue were $380000.0 (Q4 2020), $379000.0 (Q3 2020), and $379000.0 (Q2 2020) per Business Quant data.